The three heteroarene-fused anthraquinones studied herein target and downregulate tNOX to reduce SIRT1 deacetylase activity and increase Ku70 acetylation, which triggers c-Flip degradation and induces apoptosis in oral cancer cells. This evidence concerns the gene XRCC6 and lip and oral cavity carcinoma.